A collection of nonimplantable, invasive devices intended to be used to puncture the interatrial septum during a transseptal catheterization procedure, and to create a conduit for the introduction of various cardiovascular catheters into the left side of the h
| Company | Devices | Share |
|---|---|---|
| Baylis Médicale Cie Inc | 87 | 21% |
| Atraverse Medical, Inc | 61 | 15% |
| Merit Medical | 58 | 14% |
| Boston Scientific Corporation | 49 | 12% |
| St. Jude Medical, Inc. | 48 | 12% |
| Shanghai Microport Ep Medtech Co., Ltd. | 46 | 11% |
| Merit Medical Systems, Inc. | 29 | 7% |
| Circa Scientific, Inc. | 10 | 2% |
| Synaptic Medical, Ltd. | 7 | 2% |
| Rhythm Xience, Inc. | 6 | 1% |
| Acutus Medical, Inc. | 4 | 1% |
| Cook Incorporated | 3 | 1% |
Company = labeler of record on GUDID. 14 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| DXF | Catheter, Septostomy | 877 |
| DYB | Introducer, Catheter | 792 |
| DRE | Dilator, Vessel, For Percutaneous Catheterization | 342 |
| DQY | Catheter, Percutaneous | 252 |
| DYB | INTRODUCER, CATHETER | 127 |
| OFK | Percutaneous atrial catheter kit | 43 |
Use these as the dimensions to specify in a tender line.
411 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Cardiac transseptal access set", from 14 companies. The largest labeler is Baylis Médicale Cie Inc with 21% of records.
DXF (Catheter, Septostomy), DYB (Introducer, Catheter), DRE (Dilator, Vessel, For Percutaneous Catheterization), DQY (Catheter, Percutaneous)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add cardiac transseptal access set to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.